CIPLA receives approval from US FDA CIPLA receives approval from US FDA DSIJ Intelligence / Thursday, February 7, 2019 0 2524 Article rating: 5.0 Cipla’s Tadalafil Tablets 20mg is AB-rated generic therapeutic equivalent version of Eli Lilly’s Adcirca. It is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) to improve exercise ability. Read more
Glenmark receives tentative approval for Fulvestrant Inj Glenmark receives tentative approval for Fulvestrant Inj DSIJ Intelligence / Thursday, February 7, 2019 0 1496 Article rating: 5.0 Pharma major Glenmark was granted tentative USFDA approval for Fulvestrant Injection, 250 mg/5 ml. The shares of the company experienced volatility on an intraday basis. Read more
Ten stocks close to their 52-week low Ten stocks close to their 52-week low Shital Jibhe / Thursday, February 7, 2019 0 1189 Article rating: 5.0 Following stocks are close to their 52-week low as at 2.36 p.m. on February 7, 2019. Read more
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Thursday, February 7, 2019 0 998 Article rating: 3.5 The markets on February 7, 2019 opened gap up. BSE Sensex is trading at 37,108.42, up by 133.19 points and the Nifty is trading at 11,099.80, up by 37.35 points. Read more
RBI cuts repo rate by 25bps RBI cuts repo rate by 25bps DSIJ Intelligence / Thursday, February 7, 2019 0 902 Article rating: 5.0 The Reserve Bank of India (RBI) reduced policy repo rates under LAF by 25 basis points on Thursday. The Monetary Policy Committee (MPC) also changed its policy stance to neutral. Read more